Cannabis-based drug Sativyl has been approved as a treatment for cancer-related pain in Peru. Sativyl, produced by Verdemed, was created to be as similar as possible to Sativex, produced by Jazz Pharmaceuticals PLC’s GW Pharmaceuticals and is recommended for the relief of cancer symptoms and spasticity in patients with multiple sclerosis. Among other uses, Sativyl is indicated to relieve strong pain. The medication is considered an efficient, non-addictive substitute for opioids, like morphine or oxycodone. In the United States, opioids are considered a public health issue. The CDC recorded a 28.5% increase in deaths caused by opioid overdoses between April 2020 and April 2021. For the first time ever, the country surpassed the mark of 100,000 drug-related deaths over a year-long period.

420 Intel – Marijuana Industry News, 11/22/2021 19:00:00

Open article: